Anzeige
Mehr »
Lynx Broker
Login
Mittwoch, 23.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XDTV ISIN: NL0010696654 Ticker-Symbol: UQ1 
Tradegate
22.10.19
21:17 Uhr
39,660 Euro
+0,760
+1,95 %
1-Jahres-Chart
UNIQURE NV Chart 1 Jahr
5-Tage-Chart
UNIQURE NV 5-Tage-Chart
RealtimeGeldBriefZeit
38,880
39,540
19:39
38,940
39,460
19:39

Aktuelle News zur UNIQURE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.09.uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in October295LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 27, 2019(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
► Artikel lesen
25.09.Crash Protection Kicks In For uniQure14
UNIQURE Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!
20.09.uniQure N.V. - 8-K, Current Report4
06.09.uniQure prices stock offering at $46; shares down 2% premarket13
06.09.uniQure prices stock offering at $462
06.09.uniQure Inc.: uniQure Announces Pricing of its Public Offering367 LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 05, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with...
► Artikel lesen
05.09.The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug20
04.09.uniQure Inc.: uniQure Announces Proposed Public Offering395LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 04, 2019N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe unmet medical needs, today...
► Artikel lesen
03.09.uniQure N.V. - 8-K, Current Report-
03.09.UniQure achieves planned enrollment in HOPE-B trial of AMT-0615
03.09.uniQure Inc.: uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B161LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 03, 2019), an investigational AAV5-based gene therapy incorporating the patent-protected FIX-Padua variant for the treatment of patients with...
► Artikel lesen
30.08.uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in September305LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Aug. 30, 2019(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
► Artikel lesen
26.08.uniQure N.V. - 8-K, Current Report1
20.08.Executives on the move at UniQure8
20.08.uniQure Inc.: uniQure Announces Leadership Promotions and Executive Transition330LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Aug. 20, 2019N.V., M.D., Ph.D., to Executive Vice President, Research and Product Development, and Alex Kuta, Ph.D., to Executive Vice President, Operations...
► Artikel lesen
29.07.uniQure N.V. - 10-Q, Quaterly Report11
29.07.uniQure EPS misses by $0.08, beats on revenue11
29.07.uniQure Inc.: uniQure Announces Second Quarter 2019 Results and Highlights Recent Company Progress90~ Presented 36 Weeks of Follow-up Data from Phase IIb Study of AMT-061 Demonstrating Sustained Increases in FIX Activity at up to 54% of Normal ~ ~ Continuing Patient Recruitment in HOPE-B Pivotal...
► Artikel lesen
26.07.uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences57LEXINGTON, Mass. and AMSTERDAM, the Netherlands, July 26, 2019(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
► Artikel lesen
09.07.uniQure N.V. - 8-K, Current Report11
Seite:  Weiter >>
70 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1